Skip to main content
main-content

01.12.2012 | Case report | Ausgabe 1/2012 Open Access

World Journal of Surgical Oncology 1/2012

Pulmonary sclerosing hemangioma: report of two cases

Zeitschrift:
World Journal of Surgical Oncology > Ausgabe 1/2012
Autoren:
Chuang He, Hongyang Fang, Yun Liu, Xuequan Huang, Wei Zhen, Li Ren
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-10-182) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

CH carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. HYF carried out the immunoassays. YL participated in the sequence alignment. XQH and LR participated in the design of the study and performed the statistical analysis. WZ conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

Abstract

Pulmonary sclerosing hemangioma (PSH) is a rare benign tumor of the lungs. These tumors are composed of cuboidal surface cells and polygonal stromal cells and show four histological manifestations: hemorrhagic, papillary, solid, and sclerotic. PSH predominantly affects asymptomatic middle-aged women. The tumor often occurs at the intralobar site, and less commonly in the bronchus and mediastinum. PSH is easy to be misdiagnosed preoperatively. In this study, we present in detail the treatment procedures followed for two atypical cases of PSH. Case 1 was a 62-year-old woman bearing a tumor for 15 years. The tumor lesion was found to be located in the oblique fissure of the left lung. PSH was confirmed by surgical resection and postoperative pathological diagnosis. There was no sign of recurrence and metastasis 1.5 years after surgery. Case 2 was a 54-year-old woman diagnosed with bilateral multiple nodules by physical examination. This patient was diagnosed with definite PSH through computed tomography-guided percutaneous lung biopsy. Surgical resection was not performed. The patient also showed no sign of enlarged tumor and metastasis after 2 years of follow-up. Although PSH can be cured by surgical resection, the findings in our cases indicate that surgical resection need not be considered the preferred course of treatment. If PSH is diagnosed before surgery, the patients may survive while bearing the tumor.
Zusatzmaterial
Authors’ original file for figure 1
12957_2012_1075_MOESM1_ESM.tiff
Authors’ original file for figure 2
12957_2012_1075_MOESM2_ESM.tiff
Authors’ original file for figure 3
12957_2012_1075_MOESM3_ESM.tiff
Authors’ original file for figure 4
12957_2012_1075_MOESM4_ESM.png
Authors’ original file for figure 5
12957_2012_1075_MOESM5_ESM.png
Authors’ original file for figure 6
12957_2012_1075_MOESM6_ESM.png
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

World Journal of Surgical Oncology 1/2012 Zur Ausgabe

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise